Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02589594

Ligand	Ligand name	Chain	PDB	Tanimoto
4BS	4-amino-N-[4-(benzyloxy)phenyl]butanamide	A	3CHR	0.73
4BQ	(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid	A	3CHQ	0.72
323	2-[3,6-bis(dimethylamino)xanthen-9-yl]-5-methanoyl-benzoate	A,P,Q	3D1F	0.7
4BO	(3S)-3-amino-4-oxo-4-[(4-phenylmethoxyphenyl)amino]butanoic acid	A	3CHP	0.71
BN3	4-[3-CHLORO-4-({[(2,4-DICHLOROBENZOYL)AMINO]CARBONYL}AMINO)PHENOXY]BUTANOIC ACID	A	1WUY	0.71
R2C	5-METHOXY-2-[(4-PHENOXYPHENYL)AMINO]BENZOIC ACID	A	2PRL	0.75
RQ3	2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID	A,B,C,D	1G9V	0.71
C85	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	A,C	2UZD	0.71
IC1	3-[(2,4,6-TRIMETHOXY-PHENYL)-METHYLENE]-INDOLIN-2-ONE	A,B	1EH4	0.72
C75	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE	A,C	2UZB	0.71
BGF	2,5-BIS(4-GUANYLPHENYL)FURAN	A	227D	0.7
BPF	2,5-BIS{[4-(N-ETHYLAMIDINO)]PHENYL}FURAN	A,B	360D	0.71
BN4	4-[4-({[(2,4-DICHLOROBENZOYL)AMINO]CARBONYL}AMINO)-2,3-DIMETHYLPHENOXY]BUTANOIC ACID	A	1WV0	0.71
VRX	(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID	A,B	2HWI	0.76
44C		A	2FBR	0.74
4BG	N-[4-(benzyloxy)phenyl]glycinamide	A	3CHO	0.71
BRK	{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE	A	2IZR	0.84
C96	4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE	A	2UZN	0.72
RHQ	RHODAMINE 6G	A,B,D,E	1JUS	0.7
RHQ	RHODAMINE 6G	A,B,D,E	3BR5	0.7
RHQ	RHODAMINE 6G	A,D,E	3BR6	0.7
RHQ	RHODAMINE 6G	A,B	3D6Z	0.7
RHQ	RHODAMINE 6G	A	1OY8	0.7
RHQ	RHODAMINE 6G	A	1T9V	0.7
R22	4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE	A,B	2BE2	0.71
C95	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID	A,C	2UZE	0.76
D27	2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid	A,B,C,D	2VD0	0.73
ILC		A	2FPV	0.71
FMX	FAMOXADONE	C,D,E	1L0L	0.7
VR1	(2S)-2-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)-2-(4-FLUOROPHENYL)-N-[(4-NITROPHENYL)SULFONYL]ACETAMIDE	A,B	2O5D	0.73
6CA		A	2FLM	0.74
426	6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE	A	1OWI	0.71
3MR	(4S)-4-(2-AMINO-6-PHENOXYQUINAZOLIN-3(4H)-YL)-N,4-DICYCLOHEXYL-N-METHYLBUTANAMIDE	A	2Q15	0.71
D55	4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide	A	2VIQ	0.71
BN2	7-[2,6-DICHLORO-4-({[(2-CHLOROBENZOYL)AMINO]CARBONYL}AMINO)PHENOXY]HEPTANOIC ACID	A	1WUT	0.72
SCB	2-CHLORO-5-(5-{(E)-[(2Z)-3-(2-METHOXYETHYL)-4-OXO-2-(PHENYLIMINO)-1,3-THIAZOLIDIN-5-YLIDENE]METHYL}-2-FURYL)BENZOIC ACID	A,B,C,D,E,F	2GLM	0.76